Integrated Oncology Learning - Details

 

A Focus on Thoracic Malignancies

A Multiactivity Integrated Program

Approved for AMA PRA Category 1 Credit(s)

This integrated curriculum will address the personalized treatment of patients with thoracic malignancies. Each module provides learners with distinct formats useful in the various stages of learning and is designed to build on content in a logical sequence with activities that present new information and data, facilitate integration into current treatment practices, and consolidate learning.

[ Log in to see a status bar view of your new, in progress, and completed activities ]

Maintenance Therapy, Biomarkers, and Induction Therapy for Thoracic Malignancies

Module Description & Instructions

Date Available Title of Activity
JUL 2009

Oncology Briefings Vol. 7, No. 4: The Role of Maintenance Therapy and Biomarkers in Frontline Therapy for Advanced Non–Small-Cell Lung Cancer

Approved for AMA PRA Category 1 Credit(s)

Online activity reviewing recent developments in maintenance therapy and biomarkers in advanced NSCLC

Activity Release Date: July 30, 2009 view activity
SEP 2009

OncoLogue: New Developments in Maintenance Therapy for Advanced Non–Small-Cell Lung Cancer

Approved for AMA PRA Category 1 Credit(s)

Interactive Oncology Dialogue with an expert regarding issues you face in managing patients with advanced NSCLC

Activity Release Date: September 11, 2009 view activity
SEP 2009

Highlights from the 10th International Lung Cancer Congress

Selected lectures highlighting some of the best from the 10th International Lung Cancer Congress

Activity Release Date: September 1, 2009 view activity
SEP 2009

Cancer Summaries & Commentaries Vol. 2, No. 3: New Developments in Maintenance Therapy and Novel Targeted Agents for Advanced Non–Small-Cell Lung Cancer

Approved for AMA PRA Category 1 Credit(s)

Online publication and audio interview reviewing the most clinically relevant abstracts from the 45th Annual Meeting of the American Society of Clinical Oncology and the 13th World Conference on Lung Cancer

Activity Release Date: September 29, 2009 view activity
OCT 2009

Communities of Oncology Practice: Treatment Options for Advanced Non–Small-Cell Lung Cancer and Head & Neck Cancer

Approved for AMA PRA Category 1 Credit(s)

Series of activities combining e-learning with live meetings and social networking to exchange practice strategies

Activity Release Date: October 7, 2009 view activity
OCT 2009

Oncology Consultations Vol., 5, No. 4: Treatment of a Patient With Metastatic Non–Small-Cell Lung Cancer and Adenocarcinoma Histology

Approved for AMA PRA Category 1 Credit(s)

Online activity updating physicians on recent approaches to improve treatment outcomes in advanced NSCLC. This activity features an interview with Dr. Nathan A. Pennell, MD, PhD and Dr. Román Pérez-Soler, MD

Activity Release Date: October 30, 2009 view activity

IOL Overview & Purpose

Several recent developments have the potential to change the management of patients with thoracic malignancies. Numerous recent phase III trials in non–small-cell lung cancer (NSCLC) have investigated ways to improve frontline therapy for patients with advanced/metastatic disease, including the use of maintenance therapy. In patients with locally advanced head and neck cancer, induction chemotherapy has been explored. This Integrated Oncology Learning module will apprise clinicians of advances in optimizing therapy for patients with thoracic malignancies and will meet the need for continual learning with varied formats and the opportunity for interaction.

What is Integrated Oncology Learning?

A curriculum-based educational program for oncologists and hematologists from PER that is:

Comprehensive:  complete learning opportunities from a diverse team of experts

Personalized:  distinct activities in a variety of formats you can complete in any sequence

Synergistic:  modular programs consisting of related activities

Certified:  allows you to earn valuable CME credit

New to PER?

Register now for free access to Integrated Oncology Learning and other online CME activities, Email Updates, and personalized CME management!

Educational Grants

An educational grant for this Integrated Oncology Learning was provided by:


  1. Eli Lilly and Company

Continuing Education Information

Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Selected activities approved for AMA PRA Category 1 Credit

Certificates will be provided after the successful completion of each certified activity.